5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions
Enrique Calderón,1 María Eloísa Calderón-Seoane,2 Rafael García-Hernández,1 Luis Miguel Torres1 1Pain Unit, Anesthesiology Department, Puerta del Mar University Hospital, 2Health Center North-Algeciras, Cadiz, Spain Objectives: Chroni...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-10-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/5-lidocaine-medicated-plaster-for-the-treatment-of-chronic-peripheral--peer-reviewed-article-JPR |
id |
doaj-a0f46e602c7249c98933fc33c0048e45 |
---|---|
record_format |
Article |
spelling |
doaj-a0f46e602c7249c98933fc33c0048e452020-11-25T01:24:01ZengDove Medical PressJournal of Pain Research1178-70902016-10-01Volume 9763770293005% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditionsCalderón ECalderón-Seoane MEGarcía-Hernández RTorres LMEnrique Calderón,1 María Eloísa Calderón-Seoane,2 Rafael García-Hernández,1 Luis Miguel Torres1 1Pain Unit, Anesthesiology Department, Puerta del Mar University Hospital, 2Health Center North-Algeciras, Cadiz, Spain Objectives: Chronic neuropathic pain and chronic complex regional pain syndrome (CRPS), in particular, are debilitating and difficult-to-treat conditions that have a strong impact on patient’s quality of life. The aim of this study was to evaluate the effectiveness of 5% lidocaine-medicated plaster as add-on therapy in patients with chronic peripheral neuropathic pain conditions, including CRPS.Patients and methods: This was a single-center, prospective, observational study set in a specialized pain unit of a tertiary hospital in Spain. A total of 56 patients with long-standing peripheral neuropathic pain, ten of them with CRPS, received 5% lidocaine-medicated plaster as add-on analgesic therapy for 6 months.Results: After 6 months of treatment, a ≥50% reduction in pain intensity was attained by 75% of patients, as measured by numeric rating scale (NRS) for pain. The average NRS score was reduced by 61% (4.7 points), from a baseline mean score of 7.8 to an end point mean score of 3.1. Marked improvements were also observed in the CRPS group: six out of ten patients achieved a ≥50% reduction in NRS score, and the average NRS score for patients with CRPS was reduced by 51% (4.0 points), from a baseline mean score of 7.9 to an end point mean score of 3.9. The improvements in pain intensity were partially translated into a decrease in disability index and in anxiety levels.Conclusion: 5% Lidocaine-medicated plaster may be useful as add-on therapy for a number of peripheral neuropathic pain conditions, including CRPS. Keywords: peripheral neuropathic pain, complex regional pain syndrome, topical lidocaine, analgesic therapy, chronic painhttps://www.dovepress.com/5-lidocaine-medicated-plaster-for-the-treatment-of-chronic-peripheral--peer-reviewed-article-JPRPeripheral neuropathic paincomplex regional pain syndrometopical lidocaineanalgesic therapychronic pain |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Calderón E Calderón-Seoane ME García-Hernández R Torres LM |
spellingShingle |
Calderón E Calderón-Seoane ME García-Hernández R Torres LM 5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions Journal of Pain Research Peripheral neuropathic pain complex regional pain syndrome topical lidocaine analgesic therapy chronic pain |
author_facet |
Calderón E Calderón-Seoane ME García-Hernández R Torres LM |
author_sort |
Calderón E |
title |
5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions |
title_short |
5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions |
title_full |
5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions |
title_fullStr |
5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions |
title_full_unstemmed |
5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions |
title_sort |
5% lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions |
publisher |
Dove Medical Press |
series |
Journal of Pain Research |
issn |
1178-7090 |
publishDate |
2016-10-01 |
description |
Enrique Calderón,1 María Eloísa Calderón-Seoane,2 Rafael García-Hernández,1 Luis Miguel Torres1 1Pain Unit, Anesthesiology Department, Puerta del Mar University Hospital, 2Health Center North-Algeciras, Cadiz, Spain Objectives: Chronic neuropathic pain and chronic complex regional pain syndrome (CRPS), in particular, are debilitating and difficult-to-treat conditions that have a strong impact on patient’s quality of life. The aim of this study was to evaluate the effectiveness of 5% lidocaine-medicated plaster as add-on therapy in patients with chronic peripheral neuropathic pain conditions, including CRPS.Patients and methods: This was a single-center, prospective, observational study set in a specialized pain unit of a tertiary hospital in Spain. A total of 56 patients with long-standing peripheral neuropathic pain, ten of them with CRPS, received 5% lidocaine-medicated plaster as add-on analgesic therapy for 6 months.Results: After 6 months of treatment, a ≥50% reduction in pain intensity was attained by 75% of patients, as measured by numeric rating scale (NRS) for pain. The average NRS score was reduced by 61% (4.7 points), from a baseline mean score of 7.8 to an end point mean score of 3.1. Marked improvements were also observed in the CRPS group: six out of ten patients achieved a ≥50% reduction in NRS score, and the average NRS score for patients with CRPS was reduced by 51% (4.0 points), from a baseline mean score of 7.9 to an end point mean score of 3.9. The improvements in pain intensity were partially translated into a decrease in disability index and in anxiety levels.Conclusion: 5% Lidocaine-medicated plaster may be useful as add-on therapy for a number of peripheral neuropathic pain conditions, including CRPS. Keywords: peripheral neuropathic pain, complex regional pain syndrome, topical lidocaine, analgesic therapy, chronic pain |
topic |
Peripheral neuropathic pain complex regional pain syndrome topical lidocaine analgesic therapy chronic pain |
url |
https://www.dovepress.com/5-lidocaine-medicated-plaster-for-the-treatment-of-chronic-peripheral--peer-reviewed-article-JPR |
work_keys_str_mv |
AT calderone 5lidocainemedicatedplasterforthetreatmentofchronicperipheralneuropathicpaincomplexregionalpainsyndromeandotherneuropathicconditions AT calderonseoaneme 5lidocainemedicatedplasterforthetreatmentofchronicperipheralneuropathicpaincomplexregionalpainsyndromeandotherneuropathicconditions AT garciahernandezr 5lidocainemedicatedplasterforthetreatmentofchronicperipheralneuropathicpaincomplexregionalpainsyndromeandotherneuropathicconditions AT torreslm 5lidocainemedicatedplasterforthetreatmentofchronicperipheralneuropathicpaincomplexregionalpainsyndromeandotherneuropathicconditions |
_version_ |
1725119416770756608 |